The court battle over a proposed Ebola quarantine and research facility in Laikipia is not just about one project.
It has opened a wider conversation about a series of agreements signed between Kenya and the United States over the last decade – and whether Kenyans fully understood their implications.
Last week, the High Court temporarily halted plans to establish an Ebola-related facility in Nanyuki following a petition filed by the Katiba Institute.
The ruling has brought renewed scrutiny to health cooperation agreements signed by the two countries since 2015.
The Agreement
The story begins in July 2015, when Kenya and the United States signed a biosecurity agreement aimed at supporting research, surveillance and preparedness against diseases classified as biological threats.
The agreement was signed by former Health Cabinet Secretary James Macharia and former US Ambassador Robert Godec before being ratified by Parliament in 2016.
In 2022, the agreement was extended for another seven years, pushing its expiry date to April 2029.
Among its provisions, the framework allowed for future health-related projects between the two countries and established mechanisms for research collaboration, technical support and disease preparedness.
Regional Health Hub
A major turning point came in December 2024 when Kenya launched a revised foreign policy that identified the country as a future “wellness, humanitarian and health emergencies medical hub.”
Under the policy, Kenya committed to strengthening its role in responding to regional and international health emergencies, including disease outbreaks and pandemics.
The policy positioned Kenya as a country capable of hosting advanced laboratories, supporting outbreak response operations and coordinating health interventions beyond its borders.
The 2025 Health Partnership
In December 2025, Prime Cabinet Secretary Musalia Mudavadi and US Secretary of State Marco Rubio signed the Kenya-US Health Cooperation Framework in Washington.
Under the agreement, the United States committed approximately $1.6 billion to Kenya’s health sector over five years, while Kenya pledged to increase domestic health investment by about $850 million during the same period.
The agreement elevated Kenya’s role as a key health cooperation partner in Africa and laid the groundwork for additional joint health initiatives.
The Ebola Facility Controversy
Supporters argue that facilities for disease surveillance, research and emergency preparedness are consistent with Kenya’s ambition to become a regional health hub.
Critics, however, contend that the public was not adequately informed about how existing agreements and policy commitments could translate into facilities handling high-risk diseases on Kenyan soil.
The debate has therefore shifted from the technical aspects of disease preparedness to broader questions about public participation, transparency and how major international agreements are communicated to citizens.
What happens next?
For now, the proposed facility remains suspended pending the outcome of the court case.
The legal proceedings are expected to determine whether the project complies with constitutional requirements, particularly on public participation and environmental oversight.
Beyond the courtroom, the case is likely to trigger a wider national discussion about Kenya’s growing role in global health diplomacy, emergency preparedness and international research partnerships.
In a Nutshell ….
At its heart, the controversy is less about Ebola and more about Kenya’s evolving position in global health.
Over the past decade, the country has steadily expanded its role in regional disease surveillance, emergency response and international health cooperation.
The question now being debated is not whether Kenya should participate in those efforts, but how such decisions are made, communicated and implemented when they directly affect local communities.
